Navigation Links
MU researchers enhancing motion-capture technology to benefit older adults
Date:6/10/2008

COLUMBIA, Mo. The aging process often forces older adults to give up things they value and enjoy, including their independence and the ability to exercise and participate in physical activities. Researchers at the University of Missouri Center for Eldercare and Rehabilitation Technology (CERT) are working to help older adults live better lives by developing and evaluating motion-capture technology that monitors the physical functioning of older adults while preserving their privacy.

"Frequent assessment of physical function is a key indicator for detecting initial decline of health in older adults," said Marge Skubic, director of CERT and associate professor of electrical and computer engineering in the MU College of Engineering. "The technology we are developing will help health care providers identify potential health problems, which provides a window of opportunity for interventions and treatments to alleviate the problems before they become worse."

Skubic recently received a $900,000 grant from the National Science Foundation to work with an interdisciplinary team of researchers at MU and the University of Washington to advance CERT's current projects, which include an exercise feedback system and a fall recognition system.

Using existing motion capture methods, CERT researchers developed an exercise feedback system to increase exercise effectiveness and safety for older adults. The automated system uses standard Web cams to capture the silhouette sequences of participants while they exercise, and provides feedback about posture and gait, including stride, balance and body position.

"This information will help older adults understand more about their posture and movement during exercise, and lead to improved effectiveness and safety of exercise regimens," said Greg Alexander, assistant professor in the MU Sinclair School of Nursing and lead researcher of the project.

In another pro
'/>"/>

Contact: Emily Smith
SmithEA@missouri.edu
573-882-3346
University of Missouri-Columbia
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Researchers Update Risk-of-Death Charts
2. Researchers uncover higher prevalence of periodontal disease in rheumatoid arthritis patients
3. Rutgers researchers show how the brain can protect against cancer
4. Researchers block transmission of malaria in animal tests
5. U-M researchers discover traits of aggressive form of prostate cancer
6. 2collab Survey Reveals That Scientists and Researchers are "All Business" With Social Applications
7. Researchers determine risk factors for infection after liver transplantation
8. Researchers ID Inflammation-Fighting Pathway in Fat Cells
9. Virginia Tech researchers find human virus in chimpanzees
10. Brown researchers work toward ending cartilage loss
11. NARSAD researchers identify specific genes and family traits linked to mental illnesses
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
MU researchers enhancing motion-capture technology to benefit older adults
MU researchers enhancing motion-capture technology to benefit older adults
(Date:9/4/2008)... , CHAMPAIGN, Ill. Many older Americans may be s...cial Security too soon, according to a University ...irement program for nearly two decades. , More t...ly Social Security checks for life by claiming ben...tter understood the program,s options and conseque...
(Date:9/4/2008)... Officials want stronger labeling about fungal in...lthDay News) -- Federal health authorities have as...ppressive drugs to bolster safety warnings on the .... , The drugs, Humira, Cimzia, Enbrel and Remic...or necrosis factor alpha blockers (TNF-alpha block...
(Date:9/4/2008)... PACIFIC PALISADES, Calif., Sept. 4 /PRNewswi...r and recognized authority in the field of weight,... "Who,s Who in,California," "Who,s Who in The West...," "Who,s Who in Medicine and Health Care" and oth...evote his expertise to exposing the,inaccurate, mi...
(Date:9/4/2008)... HARRISBURG, Pa., Sept. 4 /PRNewswire-USNewsw...ely 250 individuals, organizations, and community,...Pennsylvania, has added,an interactive map to its ...f the water they drink contains the optimal level ...alf of Pennsylvania,s citizens currently have opti...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:FDA Demands Tougher Warnings on Immunosuppressive Drugs 2Health News:FDA Demands Tougher Warnings on Immunosuppressive Drugs 3Health News:Phone World-famed Martin Schiff, M.D., at 310-454-6172 for Free Weight Loss 'No Diet, No Stuff' Method. Hates Diets, Loves to Have People Help Themselves 2Health News:PA Fluoride NOW Debuts Interactive Map for Residents to Learn if Their Water Has the Best Fluoride Level to Protect Teeth 2Health News:PA Fluoride NOW Debuts Interactive Map for Residents to Learn if Their Water Has the Best Fluoride Level to Protect Teeth 3
...0% of youth in the United States cannot boast of a...e case with nearly 15 million// American adults wh...cession. A report from the Agency for Healthcare ...mericans who were not covered under health insuran...
... good trend of decline in the number of suicides. ...realize its goal of scaling down the suicide rates...ealth has enabled some Statistics which portray th... per 100,000 and in 2004 it had dropped to 8.56 de...
...rgos, has confirmed that a new hospital for the Be... Stating that he has directed the Area Health Se...g process for a new hospital. Stating that they wi...future health needs of the Bega community in order...
...’s or KFC restaurants, across the world, have vary...an the levels of the same // food elsewhere. Accor...ew England Journal of Medicine, the researchers an...d's chicken nuggets, KFC hot wings, french fries f...
Other Medicine News:Health News:Construction Of A New Hospital In The Bega Area Confirmed 2
(Date:9/6/2008)...rcent or Greater Concordance Compared to FISH ..., - Company to Include Reporting for HER2 Gene Exp...Reports by End of 2008 -, REDWOOD CITY, Calif., S...nc. (Nasdaq: GHDX ) today announced results from ...ing for HER2 gene expression, as measured by the,c...
(Date:9/5/2008).../PRNewswire-USNewswire/ -- The Florida,Technology,...lorida,Atlantic University researcher Dr. Herbert ... the Center for Molecular Biology and,Biotechnolog...d CHS,Resources LLC (CHS), $184,294 as part of the...tance Grant program (SURECAG). SURECAG was,establi...
(Date:9/5/2008)...., Sept. 5 /- SARcode,Corpo...e LFA-1 inhibitors,to treat inflammatory diseases,...today announced SARcode,s initiation of a Phase 1 ...andidate for T-cell mediated ophthalmic,diseases. ...nt providing,SARcode with an exclusive license to ...
(Date:9/4/2008).... 4 /- Cytopia Limited (ASX:,CYT) tod...ts Phase Ib/II,study of CYT997, the company,s nove...s with an aggressive form of brain cancer known as... trial is the first Phase II efficacy study in hig...any and the second in its,suite of Phase II studie...
Breaking Medicine Technology:Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 2Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 3Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 4Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 5Major State Grant Accelerates Research and Development of Novel Cancer Therapy 2Major State Grant Accelerates Research and Development of Novel Cancer Therapy 3SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3ICx Technologies and Siemens Medical Solutions Diagnostics Enter In Vitro Diagnostics Development and License Option Agreement 4472 1ICx Technologies and Siemens Medical Solutions Diagnostics Enter In Vitro Diagnostics Development and License Option Agreement 4472 2Immunosyn Corporation to Present at FSX 1465 1Immunosyn Corporation to Present at FSX 1465 2New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR 28R 29 28zolpidem tartrate extended release 2 633 1New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR 28R 29 28zolpidem tartrate extended release 2 633 2New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR 28R 29 28zolpidem tartrate extended release 2 633 3New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR 28R 29 28zolpidem tartrate extended release 2 633 4A new key to detecting deadly aortic aneurysms 4466 1A new key to detecting deadly aortic aneurysms 4466 2
...tudy Fails to Meet Primary Endpoint of Improvement... 2007 /PRNewswire-FirstCall/ --,Allos Therapeutics...H, the Company,s pivotal Phase 3 study of Efaproxy...y (WBRT) in women,with brain metastases originatin...its primary endpoint of demonstrating a,statistica...
...SAN DIEGO, June 20, 2007 /PRNewswire-FirstCall/ --...l company committed to,the discovery, development ...reatment of hepatitis and cancer, announced today ...inical development as an,orally-administered direc... C virus (HCV) infection. , "We have identified a ...
Other Medicine Technology:Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 2Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 3Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 4Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 5Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 6Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for,Clinical Development in Chronic Hepatitis C Virus Infection 2Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for,Clinical Development in Chronic Hepatitis C Virus Infection 3Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for,Clinical Development in Chronic Hepatitis C Virus Infection 4
Aire-Cuf® and Fome-Cuf® tracheostomy tubes with talk attachment are available in I.D. sizes from 5.0 mm to 9.5 mm. , ,Developed to aid the ventilator dependent patient in communicating with
For additional patient safety, the laryngectomy tube is designed with an integral 15 mm ISO termination that can be connected to a ventilator, with or without the inner cannula in place , ,Portex&re
The all silicone construction of the shaft and neck flange provides the utmost in patient comfort. , ,The Aire-Cuf® tracheostomy tube offers a more traditional and familiar air-filled cuff desig
...® Mid-Range Aire-Cuf® Adjustable Neck Flan...he TTS™ tube except this tube features the m...g;., ,Adult Mid-Range Aire-Cuf® Adjustable Ne...ude a trach tie, disconnect wedge, and obturator/i...
Medicine Products: